Oxadiazole: A highly versatile scaffold in drug discovery
- PMID: 35575467
- DOI: 10.1002/ardp.202200123
Oxadiazole: A highly versatile scaffold in drug discovery
Abstract
As a pharmacologically important heterocycle, oxadiazole paved the way to combat the problem associated with the confluence of many commercially available drugs with different pharmacological profiles. The present review focuses on the potential applications of five-membered heterocyclic oxadiazole derivatives, especially 1,2,4-oxadiazole, 1,2,5-oxadiazole, and 1,3,4-oxadiazole, as therapeutic agents. Designing new hybrid molecules containing the oxadiazole moiety is a better solution for the development of new drug molecules. The designed molecules may accumulate a biological profile better than those of the drugs currently available on the market. The present review will guide the way for researchers in the field of medicinal chemistry to design new biologically active molecules based on the oxadiazole nucleus. Antitubercular, antimalarial, anti-inflammatory, anti-HIV, antibacterial, and anticancer activities of various oxadiazoles have been reviewed extensively here.
Keywords: 1,3,4-oxadiazole; anti-HIV; anticancer; antitubercular; molecular docking.
© 2022 Deutsche Pharmazeutische Gesellschaft.
Similar articles
-
A Review of the Biological Activities of Heterocyclic Compounds Comprising Oxadiazole Moieties.Curr Top Med Chem. 2022;22(7):578-599. doi: 10.2174/1568026622666220202123651. Curr Top Med Chem. 2022. PMID: 35114924 Review.
-
Substituted oxadiazoles: a patent review (2010 - 2012).Expert Opin Ther Pat. 2013 Sep;23(9):1209-32. doi: 10.1517/13543776.2013.797409. Epub 2013 May 10. Expert Opin Ther Pat. 2013. PMID: 23663160 Review.
-
Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review.Eur J Med Chem. 2021 Jan 1;209:112886. doi: 10.1016/j.ejmech.2020.112886. Epub 2020 Sep 29. Eur J Med Chem. 2021. PMID: 33032083 Review.
-
A Review Exploring Therapeutic Worth of 1,3,4-Oxadiazole Tailored Compounds.Mini Rev Med Chem. 2019;19(6):477-509. doi: 10.2174/1389557518666181015152433. Mini Rev Med Chem. 2019. PMID: 30324877 Review.
-
A comprehensive review of recent advances in the biological activities of 1,2,4-oxadiazoles.Arch Pharm (Weinheim). 2022 Jul;355(7):e2200045. doi: 10.1002/ardp.202200045. Epub 2022 Apr 21. Arch Pharm (Weinheim). 2022. PMID: 35445430 Review.
Cited by
-
1,3,4-Oxadiazole Scaffold in Antidiabetic Drug Discovery: An Overview.Mini Rev Med Chem. 2024;24(20):1800-1821. doi: 10.2174/0113895575298181240410041029. Mini Rev Med Chem. 2024. PMID: 38644715 Review.
-
Synthesis and Biological Evaluation of New Quinoline and Anthranilic Acid Derivatives as Potential Quorum Sensing Inhibitors.Molecules. 2023 Aug 3;28(15):5866. doi: 10.3390/molecules28155866. Molecules. 2023. PMID: 37570836 Free PMC article.
-
Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease.RSC Adv. 2023 Jun 9;13(26):17526-17535. doi: 10.1039/d3ra01953e. eCollection 2023 Jun 9. RSC Adv. 2023. PMID: 37304812 Free PMC article.
-
Polyaromatic Hydrocarbon (PAH)-Based Aza-POPOPs: Synthesis, Photophysical Studies, and Nitroanalyte Sensing Abilities.Int J Mol Sci. 2023 Jun 13;24(12):10084. doi: 10.3390/ijms241210084. Int J Mol Sci. 2023. PMID: 37373234 Free PMC article.
-
Identification of Novel Artemisinin Hybrids Induce Apoptosis and Ferroptosis in MCF-7 Cells.Int J Mol Sci. 2022 Dec 12;23(24):15768. doi: 10.3390/ijms232415768. Int J Mol Sci. 2022. PMID: 36555409 Free PMC article.
References
REFERENCES
-
- N. A. Meanwell, J. Med. Chem. 2011, 54, 2529.
-
- T. K. Köprülü, S. Ökten, V. E. Atalay, Ş. Tekin, O. Çakmak, Med. Oncol. 2021, 38, 84.
-
- A. Gomtsyan, Chem. Heterocycl. Compd. 2012, 48, 7.
-
- E. V. Babaev, Chem. Heterocycl. Compd. 1993, 29, 796.
-
- J. Jampilek, Molecules 2019, 24, 3839.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
